Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence

Journal of Surgical Oncology

Volumn 73, Issue 2, 2000, Pages 109-114

  Poon, Ronnie Tung Ping ^a,b   Ngan, Henry ^a   Lo, Chung Mau ^a   Liu, Chi Leung ^a   Fan, Sheung Tat ^a   Wong, John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Hepatocellular carcinoma; Inoperable; Recurrence; Transarterial chemoembolization

Indexed keywords

SERUM ALBUMIN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HEPATIC ARTERY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 0033995209     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(200002)73:2<109::AID-JSO10>3.0.CO;2-J     Document Type: Article

References (27)

1. Sasaki Y, Imaoka S, Kasugai H, et al.: A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin and gelatin sponge. Cancer 1987;60:1194-1203.
2. Kasugai H, Kojima J. Tatsula M, et al.: Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989;97:965-971.
3. Ikeda K, Kumada H, Saitoh S, et al.: Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 1991:68:2150-2154.
4. Stuart K, Stokes K. Jenkins R, et al.: Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization. Cancer 1993:72:3203-3209.
5. Bronowicki JP, Vetter D. Dumas F, et al.: Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients. Cancer 1994;74:16-24.
6. Mondazzi L, Bottelli R, Brambilla G, et al.: Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: A multivariate analysis of prognostic factors. Hepatology 1994; 19:1115-1123.
7. Pelletier G, Roche A, Ink O, et al.: A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990;11:181-184.
8. Groupe d' Etude et de Traitement du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;322:1256-1261.
9. Bruix J, Llovet JM. Castells A, et al.: Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology 1998;27:1578-1583.
10. Farinati F, Maria ND, Marafin C, et al.: Unresectable hepatocellular carcinoma in cirrhosis. Survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization. Dig Dis Sci 1996;41:2332-2339.
11. Berger DH, Carrasco CH, Holn DC, Curley SA: Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: Post-treatment management and complications. J Surg Oncol 1995;60:116-121.
12. Sasaki Y, Imaoka S, Fujita M, et al.: Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma. Ann Surg 1987;206:40-47.
13. Nakoa N. Kamino K, Miura K, et al.: Recurrent hepatocellular carcinoma after partial hepatectomy: Value of treatment with transcatheter arterial chemoembolization. Am J Roentgenol 1991; 156:1177-1179.
14. Jen KS, Yang FS, Chiang HJ, et al.: Repeated operation for nodular recurrent hepatocellular carcinoma within the cirrhotic liver remnant: A comparison with transcatheter arterial chemoembolization. World J Surg 1992;16:1188-1192.
15. Park JH, Han JK, Chung JW, et al,: Postoperative recurrence of hepatocellular carcinoma: Results of transcatheter arterial chemo-embolization. Cardiovasc Intervent Radiol 1993;16:21-24.
16. Okazaki M, Yamasaki S, Ono H, et al.: Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy. Hepatogastroenterology 1993;40:320-323.
17. World Health Organization: Reporting of response: WHO handbook for reporting results of cancer treatment. Geneva: WHO Offset Publications, 1979:335-341.
18. Katsushima S, Inokuma T, Oi H. et al.: Acute hepatic failure following transarterial embolization for the treatment of hepalo-cellular carcinoma. Digestion 1997;58:189-195.
19. Ryder SD, Rizzi PM, Metivier E, et al.: Chemoembolisation with lipiodol and doxorubicin: Applicability in British patients with hepatocellular carcinoma. Gut 1996;38:125-128.
20. Okada S: Transcatheter arterial embolization for advanced hepa-tocellular carcinoma: The controversy continues (Editorial). Hep-atology 1998;27:1743-1748.
21. Yamamoto K, Masuzawa M, Kato M, et al.: Analysis of prognos-tic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization. Cancer Chemother Pharmacol 1992;31(Suppl 1): S77-81.
22. Matsumata T, Kanematsu T, Takenaka K, et al.: Patterns of in-trahepatic recurrence after curative resection of hepatocellular car-cinoma. Hepatology 1989;9:457-460.
23. Jwo SC, Chiu JH, Chau GY, et al.: Risk factors linked to recur-rence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16:1367-1371.
24. Farges O, Regimbeau JM, Belghiti J: Aggressive management of recurrence following surgical resection of hepatocellular carcinoma. Hepatogastroenterology 1998;45:1275-1280.
25. Lee PH, Lin WJ, Tsang YM, et al.: Clinical management of re-current hepatocellular carcinoma. Ann Surg 1995;222:670-676.
26. Tanikawa K, Majima Y: Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma. Hepatogastroenterology 1993;40:324-327.
27. Ishii H, Okada S, Sato T, et al.: Effect of percutaneous ethanol injection for postoperative recurrence of hepatocellular carcinoma in combination with transcatheler arterial embolization. Hepatogastroenterology 1996:43:644-650.